WitrynaMalignant pleural effusion (MPE) is a serious complication of advanced tumor, with relatively high morbidity and mortality rates, and can severely affect the quality of life and survival of patients. ... The main focus of pleural fixation is the choice of sclerosing agents, including chemotherapeutic agents, bio-immunotherapy agents, talc ... Witryna14 gru 2024 · The investigators stratified this cohort by pleural effusion (n = 196) vs no pleural effusion (n = 342) as of the immunotherapy baseline. Photo credit: Getty …
Pleural effusion is a negative prognostic factor for immunotherapy …
WitrynaDownload Figure Malignant pleural effusions (MPEs) affect approximately 15% of patients with cancer during the course of their disease, most commonly those with … Witryna16 gru 2024 · Researchers at Wake Forest School of Medicine have discovered that a nanoparticle therapeutic enhances cancer immunotherapy and is a possible new approach in treating malignant pleural effusion (MPE). canon drucker ts 6351
Treatment of malignant pleural effusions: the case for localized ...
Witryna13 kwi 2024 · (B) CT shows disease progression after 26 months of targeted therapy with aletinib; The left interlobar fissure focus and mediastinal lymph node enlargement appeared, together with pleural effusion and new massive intraperitoneal effusion. (C) CT shows that the disease was stable after 6-cycle chemotherapy combined with … Witryna15 lis 2016 · Of the treatment-related serious adverse events, pleural effusion was not reported and pericardial effusion was reported in 1 out of 287 patients (<1 %) in the … WitrynaA pleural effusion is common and is often caused by: lung infections, such as pneumonia. heart failure, which is when the heart is not pumping blood around the … canon drucker und scanner